Literature DB >> 19673440

Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration.

Jacek P Szaflik1, Janusz Błasiak, Anna Krzyanowska, Małgorzata Zaraś, Katarzyna Janik-Papis, Anna I Borucka, Katarzyna Woźniak, Jerzy Szaflik.   

Abstract

PURPOSE: To assess the association between genotypes and alleles of the C-460T polymorphism of the vascular endothelial growth factor (VEGF) gene and the risk of wet form of age-related macular degeneration (AMD).
MATERIALS AND METHODS: 100 patients with clinically diagnosed wet form of AMD and 104 healthy individuals were enrolled in this study. The patients were diagnosed by optical coherence tomography, fluorescein angiography and indocyanin green angiography. The allele-specific polymerase chain reaction was used to determine the genotypes of the C-460T polymorphism of the VEGF gene. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using a logistic regression model to assess the assoctiation betweeen genotypes of the C-460T polymorphism and AMD occurrence.
RESULTS: A difference was observed in the genotype distributions between patients and controls. An association (OR 3.04, 95% CI 1.65-5.60) was found between wet form of AMD and the C/T genotype. On the other hand, the T/T genotype displayed the protective effect against the disease.
CONCLUSION: The C-460T polymorphism of the endothelial growth factor can be considered as a potential marker for the wet form of age-related macular degeneration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19673440

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  6 in total

1.  Pooled-analysis of the associations between three polymorphisms in the VEGF gene and age-related macular degeneration.

Authors:  Yan Lu; Yuhua Shi; Chunyan Xue; Jie Yin; Zhenping Huang
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

2.  Roles of three common VEGF polymorphisms in the risk of age-related macular degeneration.

Authors:  Yuqing Liu; Siqing Hou; Weihua Lang; Dongshu Dai; Zhixue Wang; Xiangning Ji; Kun Li; Xi Zhang; Yuanyuan Zou; Jingxian Wang
Journal:  Genet Test Mol Biomarkers       Date:  2014-04

3.  The influence of genetics on response to treatment with ranibizumab (Lucentis) for age-related macular degeneration: the Lucentis Genotype Study (an American Ophthalmological Society thesis).

Authors:  Peter James Francis
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

4.  FLT1 genetic variation predisposes to neovascular AMD in ethnically diverse populations and alters systemic FLT1 expression.

Authors:  Leah A Owen; Margaux A Morrison; Jeeyun Ahn; Se Joon Woo; Hajime Sato; Rosann Robinson; Denise J Morgan; Fani Zacharaki; Marina Simeonova; Hironori Uehara; Usha Chakravarthy; Ruth E Hogg; Balamurali K Ambati; Maria Kotoula; Wolfgang Baehr; Neena B Haider; Giuliana Silvestri; Joan W Miller; Evangelia E Tsironi; Lindsay A Farrer; Ivana K Kim; Kyu Hyung Park; Margaret M DeAngelis
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

5.  Association between Vascular Endothelial Growth Factor Polymorphisms and Age-Related Macular Degeneration: An Updated Meta-Analysis.

Authors:  Martina Barchitta; Andrea Maugeri
Journal:  Dis Markers       Date:  2016-11-23       Impact factor: 3.434

6.  Vascular endothelial growth factor gene polymorphisms and association with age related macular degeneration in Indian patients.

Authors:  Divya Gupta; Vani Gupta; Vinita Singh; Swayam Prakash; Suraksha Agrawal; Shobhit Chawla; Shubha R Phadke
Journal:  Meta Gene       Date:  2016-07-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.